TransCode Therapeutics Announces Pricing of $8 Million
BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more...
Source: globenewswire.com
Page 9 - Code Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Code Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Code Therapeutics Today - Breaking & Trending Today
Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket - Adaptive Biotechnologies (NASDAQ:ADPT), Akumin (NASDAQ:AKU)
Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.
Source: benzinga.com
Why Is TransCode Therapeutics (RNAZ) Stock Down 69% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips TransCode Therapeutics stock is falling hard on Tuesday after the medical company announced a…
Source: biztoc.com
Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise
/PRNewswire/ -- FinancialNewsMedia.com News Commentary - There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid...
Source: prnewswire.com
Crude Oil Moves Higher; Cintas Earnings Top Estimates - Femasys (NASDAQ:FEMY), Cintas (NASDAQ:CTAS)
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 0.96% to 33,681.79 while the NASDAQ fell 1.24% to 13,106.70. The S&P 500 also fell, dropping, 1.20% to 4,285.24.
Source: benzinga.com